HIV can develop resistance to blockbuster antiviral lenacapavir—but at a cost to the virus

Long-acting antiviral medications are transforming HIV prevention and care, requiring only minimalistic dosing. But as the ...
Nature

HIV Resistant Mutation

HIV virus is one of the most pressing health concerns facing the modern world. Since the first reported case of HIV/AIDS in 1981, over 25 million people have died. Out of the millions of people ...
Medscape

Stanford Updates List of HIV-1 Mutations Vital to Tracking AIDS Epidemic

March 9, 2009 — An updated list of 93 surveillance drug resistance HIV-1 mutations is vital to tracking the AIDS epidemic, according to the results of a study reported in the March issue of PloS ...
Hosted on MSN

HIV resistance to lenacapavir weakens the virus's ability to replicate

Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with drug-resistant infections in 2022. While there is still no vaccine for the ...
EurekAlert!

Substantial resistance to HIV infection tied to genetic mutation

Scientists have found that people who carry one copy of a mutation that protects cells against HIV infection may be partially resistant to the virus causing AIDS. The new finding is reported in a ...
Wichita Eagle

Secret to treating HIV came thousands of years before virus ever appeared. How?

Modern-day HIV treatments may stem from a genetic mutation dating back to the Viking Age, researchers said. Steinar Engeland via Unsplash On June 5, 1981, the Centers for Disease Control and ...
C&EN

HIV can develop resistance to lenacapavir, but at a cost to the virus

Gloved fingers hold a labeled vial of lenacapavir, a clear, yellowish liquid. Lenacapavir (shown) is an antiretroviral medication used to help prevent and treat HIV. Credit: Associated Press While ...